Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by β-amyloid peptide acting through receptor for advanced glycation end products (RAGE)

Molecular and Cellular Neuroscience

Volumn 29, Issue 2, 2005, Pages 333-343

  Onyango, Isaac G ^a,b   Tuttle, Jeremy B ^a   Bennett Jr , James P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; ANTIBODY; GAMMA SECRETASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYBRID; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; HUMAN; MALE; MITOCHONDRION; NEUROTOXICITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ENDOPEPTIDASES; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; COLLAGEN TYPE XI; DNA, MITOCHONDRIAL; DOWN-REGULATION; ENDOPEPTIDASES; ENZYME INHIBITORS; FEMALE; HUMANS; HYBRID CELLS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; NEURONS; NF-KAPPA B; OXIDATIVE STRESS; PHOSPHORYLATION; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 19444381217     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2005.02.012     Document Type: Article

References (77)

1. J.W. Allen, B.A. Eldadah, X.L. Huang, S.M. Knoblach, and A.I. Faden Multiple caspases are involved in -amyloid-induced neuronal apoptosis J. Neurosci. Res. 65 2001 45 53
2. A.J. Anderson, J.H. Su, and C.W. Cotman DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay J. Neurosci. 16 1996 1710 1719
3. C. Behl, J.B. Davis, F.G. Klier, and D. Schubert Amyloid beta peptide induces necrosis rather than apoptosis Brain Res. 645 1994 253 264
4. M. Bisaglia, V. Venezia, P. Piccioli, S. Stanzione, C. Porcile, C. Russo, F. Mancini, C. Milanese, and G. Schettini Acetominophen protects hippocampal neurons and PC12 cultures from amyloid beta peptides induced oxidative stress and reduces NFkB activation Neurochem. Int. 41 2002 43 54
5. J. Brett, A.M. Schmidt, S.D. Yan, Y.S. Zou, E. Weidman, D. Pinsky, R. Nowygrod, M. Neeper, C. Przysiecki, and A. Shaw Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues Am. J. Pathol. 143 1993 1699 1712
6. A. Brunet, S.R. Datta, and M.E. Greenberg Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway Curr. Opin. Neurobiol. 11 2001 297 305
7. C.S. Casley, L. Canevari, J.M. Land, J.B. Clark, and M.A. Sharpe Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities J. Neurochem. 80 2002 91 100
8. C.K. Combs, D.E. Johnson, S.B. Cannady, T.M. Lehman, and G.E. Landreth Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins J. Neurosci. 19 1999 928 939
9. R.E. Davis, S. Miller, C. Herrnstadt, S.S. Ghosh, E. Fahy, L.A. Shinobu, D. Galasko, L.J. Thal, M.F. Beal, N. Howell, and W.D. Parker Jr. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 94 1997 4526 4531
10. R. Deane, S.D. Yan, R.K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, H. Zhu, J. Ghiso, B. Frangione, A. Stern, A.M. Schmidt, D.L. Armstrong, B. Arnold, B. Liliensiek, P. Nawroth, F. Hofman, M. Kindy, D. Stern, and B. Zlokovic RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain Nat. Med. 9 2003 907 913
11. D. Dickson The pathogenesis of senile plaques J. Neuropathol. Exp. Neurol. 56 1997 321 339
12. Y.S. Du, H. Zhu, J. Fu, S.F. Yan, A. Roher, W.W. Tourtellotte, T. Rajavashisth, X. Chen, G.C. Godman, D. Stern, and A.M. Schmidt Amyloid-b peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 94 1997 5296 5301
13. H. Dudek, S.R. Datta, T.F. Franke, M.J. Birnbaum, R. Yao, G.M. Cooper, R.A. Segal, D.R. Kaplan, and M.E. Greenberg Regulation of neuronal survival by the serine-threonine protein kinase Akt Science 275 1997 661 665
14. A. Eckert, U. Keil, C.A. Marques, A. Bonert, C. Frey, K. Schussel, and W.E. Muller Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease Biochem. Pharmacol. 66 2003 1627 1634
15. S. Estus, T.E. Golde, and S.G. Younkin Normal processing of the Alzheimer's disease amyloid beta protein precursor generates potentially amyloidogenic carboxyl-terminal derivatives Ann. N. Y. Acad. Sci. 674 1992 138 148
16. S. Estus, T.E. Golde, T. Kunishita, D. Blades, D. Lowery, M. Eisen, M. Usiak, X.M. Qu, T. Tabira, and B.D. Greenberg Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor Science 255 1992 726 728
17. T. Fernandes-Alnemri, G. Litwack, and E.S. Alnemri CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 β-converting enzyme J. Biol. Chem. 269 1994 30761 30764
18. A. Giovanni, E. Keramaris, E.J. Morris, S.T. Hou, M. O'Hare, N. Dyson, G.S. Robertson, R.S. Slack, and D.S. Park E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and Caspase 3 J. Biol. Chem. 275 2000 11553 11560
19. T.E. Golde, S. Estus, L.H. Younkin, D.J. Selkoe, and S.G. Younkin Processing of the amyloid protein precursor to potentially amyloidogenic derivatives Science 255 1992 728 730
20. K.N. Green, and C. Peers Divergent pathways account for two distinct effects of amyloid beta peptides on exocytosis and Ca2+ currents: involvement of ROS and NFkB J. Neurochem. 81 2002 1043 1051
21. H.C. Ha, and S.H Snyder Poly(ADP-ribose) polymerase-1 in the nervous system Neurobiol. Dis. 7 2000 225 239
22. C. Haass, M.G. Schlossmacher, A.Y. Hung, C. Vigo-Pelfrey, A. Mellon, B.L. Ostaszewski, I. Lieberburg, E.H. Koo, D. Schenk, and D.B. Teplow Amyloid beta-peptide is produced by cultured cells during normal metabolism Nature 359 1992 322 325
23. J. Hardy Testing times for the 'amyloid cascade hypothesis' Neurobiol. Aging 23 2002 1073 1074
24. T. Hartmann Intracellular biology of Alzheimer's disease amyloid beta peptide Eur. Arch. Psychiatry Clin. Neurosci. 249 1999 291 298
25. T. Hartmann, S.C. Bieger, B. Bruhl, P.J. Tienari, N. Ida, D. Allsop, G.W. Roberts, C.L. Masters, C.G. Dotti, K. Unsicker, and K. Beyreuther Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides Nat. Med. 3 1997 1016 1020
26. B. Kaltschmidt, M. Uherek, B. Volk, P.A. Baeuerle, and C. Kaltschmidt Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 94 1997 2642 2647
27. S.H. Kaufmann, S. Desnoyers, Y. Ottaviano, N.E. Davidson, and G.G. Poirier Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis Cancer Res. 53 1993 3976 3985
28. S.M. Khan, D.S. Cassarino, N.N. Abramova, P.M. Keeney, M.K. Borland, P.A. Trimmer, C.T. Krebs, J.C. Bennett, J.K. Parks, R.H. Swerdlow, W.D. Parker Jr., and J.P. Bennett Jr. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways Ann. Neurol. 48 2000 148 155
29. P. Kienlen-Campard, and J.N. Octave Correlation between beta-amyloid peptide production and human APP-induced neuronal death Peptides 23 2002 1199 1204
30. T. Kihara, S. Shimohama, H. Sawada, K. Honda, T. Nakamizo, H. Shibasaki, T. Kume, and A. Akaike Alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity J. Biol. Chem. 276 2001 13541 13546
31. M. King, and G. Attardi Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation Science 246 1989 500 503
32. A.H. Koyama, H. Akari, A. Adachi, F. Goshima, and Y. Nishiyama Induction of apoptosis in Hep-2 cells by infection with herpes simplex virus type 2 Arch. Virol. 143 1998 2435 2441
33. H.M. Lander, J.M. Tauras, J.S. Ogiste, O. Hori, R.A. Moss, and A.M. Schmidt Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress J. Biol. Chem. 272 1997 17810 17814
34. J.J. Li, D. Dickson, P.R. Hof, and H. Vlassara Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasis Mol. Med. 4 1998 46 60
35. L.F. Lue, D.G. Walker, L. Brachova, T.G. Beach, J. Rogers, A.M. Schmidt, D.M. Stern, and S.D. Yan Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism Exp. Neurol. 171 2001 29 45
36. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.F. Lue, D.G. Walker, P. Kuppusamy, Z.L. Zewier, O. Arancio, D. Stern, S.S. Yan, and H. Wu ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease Science 304 2004 448 452
37. D.L. Marcus, J.A. Strafaci, D.C. Miller, S. Masia, C.G. Thomas, J. Rosman, S. Hussain, and M.L. Freedman Quantitative neuronal c-fos and c-jun expression in Alzheimer's disease Neurobiol. Aging 19 1998 393 400
38. D. Martin, M. Salinas, R. Lopez-Valdaliso, E. Serrano, M. Recuero, and A. Cuadrado Effect of the Alzheimer amyloid fragment Abeta (25-35) on Akt/PKB kinase and survival of PC12 cells J. Neurochem. 78 2001 1000 1008
39. M. Masumura, R. Hata, I. Nishimura, T. Uetsuki, T. Sawada, and K. Yoshikawa Caspase-3 activation and inflammatory responses in rat hippocampus inoculated with a recombinant adenovirus expressing the Alzheimer amyloid precursor protein Brain Res., Mol. Brain Res. 80 2000 219 227
40. M.P. Mattson, S.W. Barger, B. Cheng, I. Lieberburg, V.L. Smith-Swintosky, and R.E. Rydel beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease Trends Neurosci. 16 1993 409 414
41. T. Morihara, T. Chu, O. Ubeda, W. Beech, and G.M. Cole Selective inhibition of Abeta 42 production by NSAID R-enantiomers J. Neurochem. 83 2002 1009 1012
42. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
43. M.P. Murphy, L.J. Hickman, C.B. Eckman, S.N. Uljon, R. Wang, and T.E. Golde Gamma-secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid beta peptides of varying length J. Biol. Chem. 274 1999 11914 11923
44. Onyango, I.G., Bennett Jr., J.P., Tuttle, J.B., in press. Endogenous oxidative stress in sporadic Alzheimer's disease neuronal cybrids reduces viability by increasing apoptosis through pro-death signaling pathways and is mimicked by oxidant exposure of control cybrids. Neurobiol. Dis. (available online 19th March 2005; doi:10.1016/j.nbd.2005.01.026).
45. J.K. Parks, T.S. Smith, P.A. Trimmer, J.P. Bennett Jr., and W.D. Parker Jr. Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro J. Neurochem. 76 2001 1050 1056
46. C.J. Pike, A.J. Walencewicz, C.G. Glabe, and C.W. Cotman Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures Eur. J. Pharmacol. 207 1991 367 368
47. T.T. Rohn, E. Head, J.H. Su, A.J. Anderson, B.A. Bahr, C.W. Cotman, and D.H. Cribbs Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease Am. J. Pathol. 158 2001 189 198
48. N. Sasaki, S. Toki, H. Chowei, T. Saito, N. Nakano, Y. Hayashi, M. Takeuchi, and Z. Makita Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease Brain Res. 888 2001 256 262
49. N. Sato, K. Kamino, K. Tateishi, T. Satoh, Y. Nishiwaki, A. Yoshiiwa, T. Miki, and T. Ogihara Elevated amyloid beta protein (1-40) level induces CREB phosphorylation at serine-133 via p44/42 MAP kinase (ERK1/2)-dependent pathway in rat pheochromocytoma PC12 cells Biochem. Biophys. Res. 232 1997
50. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J. Clin. Invest. 108 2001 949 955
51. L.A. Selznick, D.M. Holtzman, B.H. Han, M. Gokden, A.N. Srinivasan, E.M. Johnson Jr., and K.A. Roth In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease J. Neuropathol. Exp. Neurol. 58 1999 1020 1026
52. J.P. Sheehan, R.H. Swerdlow, W.D. Parker, S.W. Miller, R.E. Davis, and J.B. Tuttle Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease J. Neurochem. 68 1997 1221 1233
53. J.P. Sheehan, R.H. Swerdlow, S.W. Miller, R.E. Davis, J.K. Parks, W.D. Parker, and J.B. Tuttle Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease J. Neurosci. 17 1997 4612 4622
54. M. Shoji, N. Iwakami, S. Takeuchi, M. Waragai, M. Suzuki, I. Kanazawa, C.F. Lippa, S. Ono, and H. Okazawa JNK activation is associated with intracellular beta-amyloid accumulation Brain Res., Mol. Brain Res. 85 2000 221 233
55. A. Strasser, L. O'Connor, and V.M. Dixit Apoptosis signaling Annu. Rev. Biochem. 69 2000 217 245
56. J.H. Su, K.E. Nichol, and T. Sitch DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia Exp. Neurol. 163 2000 9 19
57. R.H. Swerdlow, J.K. Parks, S.W. Miller, J.B. Tuttle, P.A. Trimmer, J.P. Sheehan, J.P. Bennett Jr., R.E. Davis, and W.D. Parker Jr. Origin and functional consequences of the complex I defect in Parkinson's disease Ann. Neurol. 40 1996 663 671
58. R.H. Swerdlow, J.K. Parks, D.S. Cassarino, D.J. Maguire, R.S. Maguire, J.P. Bennett Jr., R.E. Davis, and W.D. Parker Jr. Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology 49 1997 918 925
59. S. Tanaka, M. Takehashi, N. Matoh, S. Iida, T. Suzuki, S. Futaki, H. Hamada, E. Masaliah, Y. Sugiura, and K. Ueda Generation of reactive oxygen species and activation of NFkB by non Abeta component of Alzheimer's disease amyloid J. Neurochem. 82 2002 305 315
60. G.T. Tian, C.D. Sobotka-Briner, J. Zysk, X. Liu, C. Birr, M.A. Sylvester, P.D. Edwards, C.D. Scott, and B.D. Greenberg Linear non-competitive inhibition of solubilized human-secretase by pepstatin a methylester, L685458, sulfonamides, and benzodiazepines J. Biol. Chem. 277 2002 31499 31505
61. P.A. Trimmer, R.H. Swerdlow, J.K. Parks, P. Keeney, J.P. Bennett Jr., S.W. Miller, R.E. Davis, and W.D. Parker Jr. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines Exp. Neurol. 162 2000 37 50
62. P.A. Trimmer, P.M. Keeney, M.K. Borland, F.A. Simon, J. Almeida, R.H. Swerdlow, J.P. Parks, W.D. Parker Jr., and J.P. Bennett Jr. Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture Neurobiol. Dis. 15 2004 29 39
63. C.M. Troy, S.A. Rabacchi, Z. Xu, A.C. Maroney, T.J. Connors, M.L. Shelanski, and L.A. Greene beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation J. Neurochem. 77 2001 157 164
64. Y. Verdier, M. Zarandi, and B. Penke Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease J. Pept. Sci. 10 2004 229 248
65. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan, and D.J. Selkoe Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
66. R. Williamson, T. Scales, B.R. Clark, G. Gibb, C.H. Reynolds, S. Kellie, I.N. Bird, I.M. Varndell, P.W. Sheppard, I. Everall, and B.H. Anderton Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases J. Neurosci. 22 2002 10 20
67. O. Wirths, G. Multhaup, and C. Czech Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice Neurosci. Lett. 306 2001 116 120
68. O. Wirths, G. Multhaup, and T.A. Bayer A modified b-amyloid hypothesis: intraneuronal accumulation of the b-amyloid peptide-The first step of a fatal cascade J. Neurochem. 91 2004 513 520
69. S. Yan, S.F. Yan, X. Chen, J. Fu, M. Chen, P. Kuppusamy, M. Smith, G. Perry, G. Godman, P. Nawroth, J. Zweier, and D.M. Stern Nonenzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of Ab Nat. Med. 1 1995 693 699
70. S.D. Yan, X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern, and A.M. Schmidt RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease Nature 382 1996 685 691
71. S.D. Yan, D. Stern, and A.M. Schmidt What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose Eur. J. Clin. Invest. 27 1997 179 181
72. S. Yan, D. Stern, M.D. Kane, Y.M. Kuo, H.C. Lampert, and A.E. Roher RAGE-AB interactions in the pathophysiology of Alzheimer's disease Restor. Neurol. Neurosci. 12 1998 167 173
73. M. Yoshizumi, Y. Fujita, Y. Izawa, Y. Suzaki, M. Kyaw, N. Ali, K. Tsuchiya, S. Kagami, S. Yano, S. Sone, and T. Tamaki Ebselen inhibits tumor necrosis factor-alpha-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells Exp. Cell Res. 292 2004 1 10
74. J. Yuan, and B.A. Yankner Apoptosis in the nervous system Nature 407 2000 802 809
75. L. Zhang, D.R. Rubinow, G. Xaing, B.S. Li, Y.H. Chang, D. Maric, J.L. Barker, and W. Ma Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt NeuroReport 12 2001 1919 1923
76. H. Zhou, X.M. Li, J. Meinkoth, and R.N. Pittman Akt regulates cell survival and apoptosis at a postmitochondrial level J. Cell Biol. 151 2000 483 494
77. X. Zhu, A.K. Raina, C.A. Rottkamp, G. Aliev, G. Perry, H. Boux, and M.A. Smith Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease J. Neurochem. 76 2001 435 441